Ads will begin in September for the line extension from Advil maker Whitehall-Robins, and include both 15-second spots and tags on current ads. The product, in both grape and fruit flavors, began shipping mid-June. Packaging is similar to that of Children's Advil suspension; the box front shows the silhouette of a sitting baby and a picture of a medicine dropper. Packaging notes the product is for ages two to three years. The product bears standard pediatric directions for use, providing dosing for 24- to 35-pound children between two and three, adding that for children under two, caregivers should consult a doctor...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
Advanz Pharma would have had to show that the European Commission’s decision to revoke Ocaliva’s conditional marketing approval risked causing serious and irreparable harm, according to lawyers from Van Bael & Bellis.
We are conducting a survey to better understand our subscribers’ content and delivery needs. If there are any changes you’d like to see in coverage topics, article format, or the method in which you access the Pink Sheet – or if you love it how it is – now is the time to have your voice heard.
Companies with significant exposure to Medicare and Medicaid have fewer options for passing along higher costs to consumers because of price controls in the programs.
There are now three draft versions of the legislative text that will overhaul the framework governing pharmaceuticals in the EU. Lawyers explain how the approaches proposed by the European Commission, European Parliament and Council of the EU differ and highlight implications for industry.